US BANCORP \DE\ - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 43 filers reported holding REDHILL BIOPHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2022$0
-100.0%
7020.0%0.00%
Q2 2022$1,000
-50.0%
7020.0%0.00%
Q1 2022$2,0000.0%7020.0%0.00%
Q4 2021$2,000
-33.3%
7020.0%0.00%
Q3 2021$3,000
+200.0%
702
+312.9%
0.00%
Q4 2020$1,0000.0%170
+56.0%
0.00%
Q3 2020$1,0001090.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q4 2022
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 367,346$926,0000.15%
DISCIPLINED GROWTH INVESTORS INC /MN 1,950,002$4,914,0000.11%
Claret Asset Management Corp 95,430$240,0000.05%
Annandale Capital, LLC 43,532$110,0000.04%
ARK Investment Management 861,798$2,172,0000.01%
Virtu Financial LLC 26,864$68,0000.01%
Ancora Advisors LLC 82,048$207,0000.01%
OSAIC HOLDINGS, INC. 4,600$1,372,0000.00%
TWO SIGMA SECURITIES, LLC 25,499$64,0000.00%
ATTICUS WEALTH MANAGEMENT, LLC 2,425$6,0000.00%
View complete list of REDHILL BIOPHARMA LTD shareholders